Cosaic raises US$6 million seed extension to scale yeast-derived ingredient platform with backing from dsm-firmenich Ventures

Cosaic has raised a US$6 million seed extension as the Swiss food biotech company moves to advance its yeast-derived multifunctional ingredient platform with backing from dsm-firmenich Ventures and other investors.

• Cosaic has raised a US$6 million seed extension with participation from dsm-firmenich Ventures, a Swiss family office, Kickfund, and existing investors including Navus Ventures and Zuercher Kantonalbank.
• The company has developed yeast-derived multifunctional ingredients designed to deliver creaminess, stability, and functionality in a single ingredient for food and beverage manufacturers.
• The financing will support regulatory work, production scale-up, and industrial trials with large clients as Cosaic works toward market readiness.

The Zurich-based startup confirmed that the round included dsm-firmenich Ventures, the venture arm of dsm-firmenich, alongside a large Swiss family office, Swiss deeptech investor Kickfund, and existing backers Navus Ventures and Zuercher Kantonalbank.

The financing comes at a time when capital remains more selective across foodtech, with investors placing greater emphasis on companies that can demonstrate both technical differentiation and a clear route to commercialization. Cosaic’s platform has been developed around yeast fermentation and aims to help food and beverage manufacturers deliver creaminess, stability, and functionality through a single ingredient, reducing the need for multiple additives or components in finished products.

The company’s approach reflects a shift in ingredient innovation, with greater focus on functional performance within formulations rather than direct one-to-one replacements. By addressing multiple formulation challenges at once, Cosaic is targeting practical needs for manufacturers balancing sensory performance, clean label requirements, and cost.

Tomas Turner, Co-founder & CEO of Cosaic, said the funding highlighted continued investor support for companies able to deliver both technical value and commercial credibility. “This round sends a clear signal: the market is backing foodtech companies that can deliver real functional value and a credible path to commercialization,” he said. “At Cosaic, we are building an ingredient that resolves the trade-offs food companies face every day between clean label, sensory performance, and cost. With strong strategic backing and a capital-efficient scale-up model, we are well positioned to move from development to launch readiness.”

The company stated that the new capital would be directed toward three core priorities as it moves toward market readiness: regulatory progress, production scale-up, and industrial trials with large clients. These steps are expected to support the transition from development-stage platform to commercial ingredient supply.

The announcement follows a strategic go-to-market partnership with Ingredion, disclosed in late 2025, which provided commercial validation from an established ingredient company. With backing now from both Ingredion and dsm-firmenich Ventures, Cosaic is progressing its efforts to move from product development toward market launch.

The company’s platform sits within a broader wave of fermentation-enabled food innovation, but its focus remains on solving established formulation challenges across categories. Creaminess, stability, and functionality are core requirements in many food and beverage applications, and ingredients capable of delivering across all three may offer manufacturers a more streamlined approach to product development.

As Cosaic advances into its next phase, the focus will shift toward execution across regulatory pathways, scaled production, and real-world performance in customer applications, supported by strategic and financial backing from industry-aligned investors.